biohacking$bioLLM CA: TBA

database / immune

Melittin

preclinical immune immune modified — mass check n/a
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOONNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
201 heavy atoms · 432 bonds · drag to pan, scroll to zoom C131N39O31

Skeletal structure drawn from the computed atomic coordinates in PubChem CID 16133648. Carbons are implicit vertices; hydrogens on carbon are suppressed, as in any structural formula. Nothing here is estimated — every atom sits where PubChem placed it.

Research reference only. The observations below are recorded in the cited literature. Nothing here is advice or a recommendation, and no dosing information is published on this site.

Sequence

GIGAVLKVLTTGLPALISWIKRKRQQ

Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln

1. Gly — Glycine · glycine · hydropathy -0.4 · charge 0G12. Ile — Isoleucine · hydrophobic · hydropathy 4.5 · charge 0I3. Gly — Glycine · glycine · hydropathy -0.4 · charge 0G4. Ala — Alanine · hydrophobic · hydropathy 1.8 · charge 0A5. Val — Valine · hydrophobic · hydropathy 4.2 · charge 0V6. Leu — Leucine · hydrophobic · hydropathy 3.8 · charge 0L67. Lys — Lysine · positive · hydropathy -3.9 · charge +1K8. Val — Valine · hydrophobic · hydropathy 4.2 · charge 0V9. Leu — Leucine · hydrophobic · hydropathy 3.8 · charge 0L10. Thr — Threonine · polar · hydropathy -0.7 · charge 0T11. Thr — Threonine · polar · hydropathy -0.7 · charge 0T1112. Gly — Glycine · glycine · hydropathy -0.4 · charge 0G13. Leu — Leucine · hydrophobic · hydropathy 3.8 · charge 0L14. Pro — Proline · proline · hydropathy -1.6 · charge 0P15. Ala — Alanine · hydrophobic · hydropathy 1.8 · charge 0A16. Leu — Leucine · hydrophobic · hydropathy 3.8 · charge 0L1617. Ile — Isoleucine · hydrophobic · hydropathy 4.5 · charge 0I18. Ser — Serine · polar · hydropathy -0.8 · charge 0S19. Trp — Tryptophan · aromatic · hydropathy -0.9 · charge 0W20. Ile — Isoleucine · hydrophobic · hydropathy 4.5 · charge 0I21. Lys — Lysine · positive · hydropathy -3.9 · charge +1K2122. Arg — Arginine · positive · hydropathy -4.5 · charge +1R23. Lys — Lysine · positive · hydropathy -3.9 · charge +1K24. Arg — Arginine · positive · hydropathy -4.5 · charge +1R25. Gln — Glutamine · polar · hydropathy -3.5 · charge 0Q26. Gln — Glutamine · polar · hydropathy -3.5 · charge 0Q26

Modified molecule. C-terminal amide.

Backbone carries modifications, so computed backbone mass is not comparable to the reported mass of the complete molecule.

Molecular data

Chemical fields come from the PubChem compound record; computed values are derived from the sequence shown above.
molecular formulaC131H229N39O31
molecular weight2846.5 Da (PubChem)
computed backbone mass2847.49 Da
length26 residues
net charge (pH 7.4)+5
mean hydropathy0.27
half-lifenot characterised
delivery routenot characterised
PubChem CID16133648
PDB2MLT
UniProt parentnot characterised

Mechanism

Amphipathic membrane-lytic peptide from honeybee venom; a standard model of pore formation.

Reported targets: lipid bilayers

Experimental structure

α-carbon backbone trace rendered from the deposited coordinates of PDB 2MLT. This is measured structure, not a prediction.

Helical wheel

1. Gly — Glycine · glycineG2. Ile — Isoleucine · hydrophobicI3. Gly — Glycine · glycineG4. Ala — Alanine · hydrophobicA5. Val — Valine · hydrophobicV6. Leu — Leucine · hydrophobicL7. Lys — Lysine · positiveK8. Val — Valine · hydrophobicV9. Leu — Leucine · hydrophobicL10. Thr — Threonine · polarT11. Thr — Threonine · polarT12. Gly — Glycine · glycineG13. Leu — Leucine · hydrophobicL14. Pro — Proline · prolineP15. Ala — Alanine · hydrophobicA16. Leu — Leucine · hydrophobicL17. Ile — Isoleucine · hydrophobicI18. Ser — Serine · polarS

Residues projected at 100° per turn, the standard α-helix rotation. Shown because helicity in this peptide is described in the cited literature.

Reported effects

Each row is an outcome described in the literature indexed for this peptide. Reported in the cited work — not a claim, not a recommendation.

Reported observations and the corpus they are drawn from.
reported outcomewhere it appears
membrane lysisMelittin- and Apamin-Standardized Bee Venom: UHPLC-ESI-MS Characterization, … Molecules (Basel, Switzerland) 2026
antimicrobial activityOptimizing separation conditions for melittin purification from bee venom us… Biophysical chemistry 2026
anti-tumour activity in modelsMelittin intervention induces lncRNA response, mitochondrial dysfunction, an… bioRxiv 2026

Literature (8)

Melittin- and Apamin-Standardized Bee Venom: UHPLC-ESI-MS Characterization, Antibacterial Activity, and Apoptosis Induction in Human Keratinocytes — Molecules (Basel, Switzerland) 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42653870 · DOI 10.3390/molecules31162787

Optimizing separation conditions for melittin purification from bee venom using molecular dynamics simulations — Biophysical chemistry 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42567113 · DOI 10.1016/j.bpc.2026.107702

Melittin intervention induces lncRNA response, mitochondrial dysfunction, and cell proliferation in murine cervical cancer cells — bioRxiv 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · DOI 10.64898/2026.08.18.745438

Melittin Reprograms Tumor-Associated Macrophages Through CD18-Mediated Immunomodulation — Phytotherapy research : PTR 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42625356 · DOI 10.1002/ptr.70431

Melittin attenuates imiquimod-induced psoriatic dermatitis in mice: a role for autophagy activation via PI3K/Akt/mTOR pathway suppression — Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42560464 · DOI 10.1007/s44446-026-00105-y

The effect of melittin intervention on murine cervical cancer cells: An in-depth proteomics investigation — bioRxiv 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · DOI 10.64898/2026.08.02.742264

Melittin in Aggressive Breast Cancer Therapy: Mechanisms, Delivery Systems, and Clinical Potential. — Current pharmaceutical design 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42669989 · DOI 10.2174/0113816128489493260728120022

Deciphering the Effect of Melittin on Murine Cervical Cancer Cells Based on Transcriptomic Investigation — bioRxiv 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · DOI 10.64898/2026.07.29.741659

Related

KPV

immune · 8 citations

Tuftsin

immune · 8 citations

Thymosin α1

immune · 8 citations

LL-37

immune · 8 citations

Human β-defensin 2

immune · 8 citations

Thymulin

immune · 8 citations